Company profile

Virta Health

Chronic Disease Management & Digital Therapeutics

Company profile

About Virta Health

Virta Health is a leader in metabolic disease reversal, specializing in type 2 diabetes reversal and sustainable weight loss through a personalized, nutrition-first approach. The company delivers virtual care through an easy-to-use mobile app that connects members with physicians, nurse practitioners, and health coaches who provide high-touch, individualized support. Virta's proprietary methodology, The Virta Method™, focuses on personalized nutrition tailored to each member's unique metabolism, emphasizing whole foods low in sugar and carbohydrates while incorporating healthy fats and proteins. This approach addresses the root cause of metabolic dysfunction rather than simply managing symptoms. The platform includes continuous remote monitoring using connected devices like digital scales and blood glucose meters, along with AI-powered nutrition support called Virta Metabolic Intelligence that helps members understand how food choices affect their body and progress. Virta partners with employers, health plans, and healthcare providers across all 50 states to deliver transformative outcomes. The company's clinical results demonstrate an average weight loss of 31 pounds, 63% medication elimination rate among diabetes patients, and an average A1c reduction of 1.3 points at one year. Virta also offers integrated GLP-1 medication management as part of its comprehensive approach to weight loss and metabolic health. The company is on a mission to solve the nation's diabetes and obesity epidemics by making disease reversal—not just management—the new standard of care.

Company description Virta Health official website

Primary marketChronic Disease Management & Digital Therapeutics
Commercial modelCommercial information available on request
Company presenceLinkedIn X
Work at Virta Health?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Metabolic Syndrome
  • Obesity
  • Prediabetes
  • Type 2 Diabetes

Who it serves

  • ASO
  • Commercial Fully-insured
  • Employers
  • Health Plans
  • Healthcare Providers
  • Medicare Advantage

Deployment & integration

Cloud Saas · Embedded deployment with recorded integration context.

Geographic context

MarketsUnited States (all 50 states)
Company sourceOfficial website

Company milestones

Platform expansion

Published Inaugural Report on Metabolic Disease Reversal; launched Virta Metabolic Intelligence AI-powered nutrition support; expanded GLP-1 medication management program (Virta for Weight Loss+); new USDA Dietary Guidelines co-authored by Virta co-founder reflecting nutrition-first approach

Partnerships

Recorded partners

  • Blue Shield of California

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

The Virta Method

Personalized nutrition tailored to each member's unique metabolism

Service · Cloud SaaSCompany source

Virta for Diabetes Management

Monitor and control blood sugar while providing a path to reversal

Platform · Cloud SaaSCompany source

Virta for Diabetes Reversal

Safely deprescribe diabetes medications and return blood sugar to subdiabetic levels

Platform · Cloud SaaSCompany source

Virta for Weight Loss

Deliver clinically significant weight loss comparable to existing weight-loss drugs

Platform · Cloud SaaSCompany source

Virta for Weight Loss+

Nutrition-first care paired with GLP-1 medications and expert management

Platform · Cloud SaaSCompany source

Virta Metabolic Intelligence

AI-powered nutrition support showing how food choices affect your body

Software · EmbeddedCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Average weight loss of 31 lbs (13%)

At one year for members with type 2 diabetes

63% medication elimination

Percent of total diabetes prescriptions eliminated (excluding metformin) at one year

Average A1c reduction of 1.3 points (3.0%)

Blood sugar improvement at one year

59% reduced diabetes medications

Medication reduction rate

Over 1 million pounds lost

Cumulative weight loss across member population

90% member satisfaction with health coach

Internal survey 12/2023-3/2024

70% find it easy to eat healthy with Virta

Internal survey 4/2024

Blue Shield of California

Integrated metabolic care for health plan members with diabetes, prediabetes, and obesity

Dan (Individual Member)

Diabetes reversal and weight loss after Ozempic

Lost 110 pounds, reversed diabetes, eliminated Ozempic and several diabetes medications, walking 8-10 miles daily

Donnie (Individual Member)

Diabetes reversal and medication reduction

A1c reduced from 11% to 6% in 10 weeks, insulin reduced from 110 units to 3 units daily

Kevin (Individual Member)

Diabetes reversal and medication elimination

Got off insulin and saved $500/month

Kristina (Individual Member)

Type 2 diabetes reversal and weight loss

A1c reduced from uncontrolled to 5.5%, lost 65 pounds, cholesterol improved, BMI normalized

Linda (Individual Member)

Weight loss and medication reduction avoiding bariatric surgery

Lost 65 pounds, reduced medications

Sheila (Individual Member)

Diabetes reversal in high-risk population

Reversed diabetes, lost over 20 pounds, regained energy

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Virta Health

Recent articles published on Virta Health's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Chronic Disease Management & Digital Therapeutics

Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon